HGEN News and Press, Humanigen Inc. From 09/29/23

Kalera Public Limited Company (KALRQ) is expected to report for quarter end 2023-06-30 Humanigen Inc. (HGEN) is expected to report for Q2 2023 Ever-Glory International Group Inc. (EVKG) is expected to report for quarter end 2023-06-30 SunCar Technology Group Inc. (SDA) is expected to ...

Regenicin Inc (RGIN) is expected to report for quarter end 2023-06-30 Grasim Industries Ltd. ADR (GRSXY) is expected to report for quarter end 2023-06-30 Mitsubishi Heavy Industries Ltd. (MHVYF) is expected to report for Q1 2024 Japan Tobacco Inc. ADR (JAPAY) is expected to report $0....

World Copper (WCUFF) is expected to report $-0.01 for Q2 2023 GlassBridge Enterprises Inc (GLAE) is expected to report for quarter end 2023-06-30 Paladin Energy Ltd (PALAF) is expected to report for Q4 2023 Andritz AG ADR (ADRZY) is expected to report for Q2 2023 Cincinnati Bancor...

Anebulo Pharmaceuticals Inc. (ANEB) is expected to report for Q4 2023 Minera IRL Ltd ADR (MRLLY) is expected to report for Q3 2023 OpenLocker Holdings Inc (OLKR) is expected to report for Q1 2024 Rent the Runway Inc. (RENT) is expected to report $-0.43 for Q2 2024 Sompo Holdings I...

Greenrose Holding Company Inc The Com (GNRS) is expected to report for quarter end 2023-06-30 Bridgford Foods Corporation (BRID) is expected to report for Q1 2024 Compagnie financiere Richemont SA ADR (CFRUY) is expected to report for Q1 2024 Kalera Public Limited Company (KALRQ) is e...

Humanigen Inc. (HGEN) is expected to report for Q2 2023

The RATinG ( R isk A dapted T herapy in Acute G vHD) is the first trial to explore granulocyte-macrophage colony-stimulating factor (GM-CSF) neutralization for the early treatment of participants with high-risk acute Graft versus Host Disease Planned interim assessment expected in 2024 ...

2023-07-25 09:35:46 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Biogen (NASDAQ: BIIB ) layoffs are on the way as the company seeks further profits with its new Alzheimer’s disease drug launch. This has the pharmaceutical company p...

2023-07-25 08:46:32 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bellerophon Therapeutics (NASDAQ: BLPH ) stock is losing value on Tuesday after the clinical-stage therapeutics company was sent a delisting notice . The Listing Qualifi...

2023-07-25 08:29:09 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Humanigen (NASDAQ: HGEN ) stock is falling hard on Tuesday after the company warned investors it can’t keep listing requirements . According to a filing from the ...